“These results are really exciting. This could be a new front in the fight against MS.”
Researchers at Oregon Health & Science University have discovered that an antioxidant designed by scientists more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease.
The antioxidant — called MitoQ — has shown some promise in fighting neurodegenerative diseases. But this is the first time it has been shown to significantly reverse an MS-like disease in an animal.
The discovery could lead to an entirely new way to treat multiple sclerosis, which affects more than 2.3 million people worldwide.
Multiple sclerosis occurs when the body’s immune system attacks the myelin, or the protective sheath, surrounding nerve fibers of the central nervous system. Some underlying nerve fibers are destroyed. Resulting symptoms can include blurred vision and blindness, loss of balance, slurred speech, tremors, numbness and problems with memory and concentration.
The antioxidant research was published in the December edition of Biochimica et Biophysica Acta Molecular Basis of Disease. The research team was led by P. Hemachandra Reddy, Ph.D., an associate scientist in the Division of Neuroscience at OHSU’s Oregon National Primate Research Center.
To conduct their study, the researchers induced mice to contract a disease called experimental autoimmune encephalomyelitis, or EAE, which is very similar to MS in humans. They separated mice into four groups: a group with EAE only; a group that was given the EAE, then treated with the MitoQ; a third group that was given the MitoQ first, then given the EAE; and a fourth “control” group of mice without EAE and without any other treatment.
After 14 days, the EAE mice that had been treated with the MitoQ exhibited reduced inflammatory markers and increased neuronal activity in the spinal cord — an affected brain region in MS — that showed their EAE symptoms were being improved by the treatment. The mice also showed reduced loss of axons, or nerve fibers and reduced neurological disabilities associated with the EAE. The mice that had been pre-treated with the MitoQ showed the least problems. The mice that had been treated with MitoQ after EAE also showed many fewer problems than mice who were just induced to get the EAE and then given no treatment.
“The MitoQ also significantly reduced inflammation of the neurons and reduced demyelination,” Reddy said. “These results are really exciting. This could be a new front in the fight against MS.”
Even if the treatment continues to show promise, testing in humans would be years away. The next steps for Reddy’s team will be to understand the mechanisms of MitoQ neuroprotection in different regions of the brain, and how MitoQ protects mitochondria within the brain cells of the EAE mice. Mitochondria, components within all human cells, convert energy into forms that are usable by the cell.
There is a built-in advantage with MitoQ. Unlike many new drugs, MitoQ has been tested for safety in numerous clinical trails with humans. Since its development in the late 1990s, researchers have tested MitoQ’s ability to decrease oxidative damage in mitochondria.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- Multiple Sclerosis Drugs and Treatment Market - Global Industry Is Expected To Grow At A CAGR Of 6% By End of 2027on May 13, 2020 at 6:56 am
The market for multiple sclerosis drugs and treatment is anticipated to grow at a significant CAGR of about 6% during the forecast period, i.e., 2019-2027 Research Nester Released a Report titled ...
- Before dying of COVID-19, Marguerite McDonald created paintings inspired by a multiple sclerosis diagnosison May 12, 2020 at 4:28 pm
An artist accustomed to adversity, Marguerite McDonald kept painting and drawing for 25 years after being diagnosed with multiple sclerosis, only stopping when she was diagnosed with COVID-19.
- Multiple Sclerosis Tied to Increased Risk for Stroke, CVD, Deathon May 12, 2020 at 2:24 pm
Patients with MS have a significantly increased risk for stroke, cardiovascular disease, and mortality. The finding points to the need for early and aggressive lifestyle interventions.
- Health experts discuss impact of Covid-19 on Multiple Sclerosis patients, latest coronavirus treatments & hospitalization trendson May 12, 2020 at 11:08 am
That includes the Hartford HealthCare Ayer Neuroscience Institute’s Multiple Sclerosis Center. Doctor Derek Smith, a neurologist, tells us about the Multiple Sclerosis program at Hartford HealthCare ...
- China approves Novartis' multiple sclerosis treatment Mayzenton May 9, 2020 at 12:30 am
Chinese regulators have approved Novartis' Mayzent to treat relapsing multiple sclerosis in adults, the Swiss drug maker said in a statement on Saturday.
- A multiple sclerosis drug may speed COVID-19 recoveryon May 8, 2020 at 3:44 pm
One form of interferon may boost the immune system’s ability to fight the coronavirus early in infections, a small study suggests.
- Aluminium in human brain tissue from donors without neurodegenerative disease: A comparison with Alzheimer’s disease, multiple sclerosis and autismon May 8, 2020 at 7:16 am
A burgeoning number of studies are demonstrating aluminium in human brain tissue. While research has both quantified and imaged aluminium in human brain tissue in neurodegenerative and ...
- Selma Blair Posts Video Walking In New Leg Braces Amidst Multiple Sclerosis Battleon May 6, 2020 at 12:33 pm
Selma Blair regularly keeps fans updated on her MS symptoms and treatment on Instagram, but she’s been pretty quiet about her health lately. Now, she’s back with new info, and ...
- Belong.Life Launches All-in-One Networking and Navigation App to Support Multiple Sclerosis Patients and Professionalson May 4, 2020 at 1:00 pm
Belong.Life, a developer of social networks for managing and navigating treatments, and the creator of the world's largest social network ...
- 'I've Run 11 Marathons but Just Received a Multiple Sclerosis Diagnosis During the Pandemic'on May 2, 2020 at 12:00 am
I celebrated my 40th birthday, got married, the COVID-19 pandemic hit and I've been diagnosed with multiple sclerosis (MS). I live just outside of Basingstoke, England, with my husband Neil, and my ...
via Bing News